CAN – Cann Group Ltd

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Cann Group Limited is an Australia-based company, which is focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. The Company is a developer and supplier of cannabis, cannabis resin and medicinal cannabis products. It also owns Satipharm, a Europe-based business licensed to manufacture, develop and market the Gelpell delivery system for cannabinoids. The Company has established research and cultivation facilities in Melbourne and is developing a cultivation and manufacturing facility near Mildura, Victoria. The Company focuses on plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercializing a range of imported and locally sourced and manufactured medicinal cannabis products.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses